335 related articles for article (PubMed ID: 15722633)
1. Characterization of wild-type recombinant Bet v 1a as a candidate vaccine against birch pollen allergy.
Batard T; Didierlaurent A; Chabre H; Mothes N; Bussières L; Bohle B; Couret MN; Ball T; Lemoine P; Focks Tejkl M; Chenal A; Clément G; Dupont F; Valent P; Krauth MT; André C; Valenta R; Moingeon P
Int Arch Allergy Immunol; 2005 Mar; 136(3):239-49. PubMed ID: 15722633
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of a birch pollen minor allergen, Bet v 5, belonging to a family of isoflavone reductase-related proteins.
Karamloo F; Schmitz N; Scheurer S; Foetisch K; Hoffmann A; Haustein D; Vieths S
J Allergy Clin Immunol; 1999 Nov; 104(5):991-9. PubMed ID: 10550744
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal digestion of Bet v 1-homologous food allergens destroys their mediator-releasing, but not T cell-activating, capacity.
Schimek EM; Zwölfer B; Briza P; Jahn-Schmid B; Vogel L; Vieths S; Ebner C; Bohle B
J Allergy Clin Immunol; 2005 Dec; 116(6):1327-33. PubMed ID: 16337467
[TBL] [Abstract][Full Text] [Related]
6. Folded or Not? Tracking Bet v 1 Conformation in Recombinant Allergen Preparations.
Husslik F; Hanschmann KM; Krämer A; Seutter von Loetzen C; Schweimer K; Bellinghausen I; Treudler R; Simon JC; Vogel L; Völker E; Randow S; Reuter A; Rösch P; Vieths S; Holzhauser T; Schiller D
PLoS One; 2015; 10(7):e0132956. PubMed ID: 26186356
[TBL] [Abstract][Full Text] [Related]
7. Ara h 8, a Bet v 1-homologous allergen from peanut, is a major allergen in patients with combined birch pollen and peanut allergy.
Mittag D; Akkerdaas J; Ballmer-Weber BK; Vogel L; Wensing M; Becker WM; Koppelman SJ; Knulst AC; Helbling A; Hefle SL; Van Ree R; Vieths S
J Allergy Clin Immunol; 2004 Dec; 114(6):1410-7. PubMed ID: 15577846
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of recombinant T1, a non-allergenic periwinkle (Catharanthus roseus) protein, with sequence similarity to the Bet v 1 plant allergen family.
Laffer S; Hamdi S; Lupinek C; Sperr WR; Valent P; Verdino P; Keller W; Grote M; Hoffmann-Sommergruber K; Scheiner O; Kraft D; Rideau M; Valenta R
Biochem J; 2003 Jul; 373(Pt 1):261-9. PubMed ID: 12656672
[TBL] [Abstract][Full Text] [Related]
9. In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test.
Erdmann SM; Sachs B; Schmidt A; Merk HF; Scheiner O; Moll-Slodowy S; Sauer I; Kwiecien R; Maderegger B; Hoffmann-Sommergruber K
Int Arch Allergy Immunol; 2005 Mar; 136(3):230-8. PubMed ID: 15713985
[TBL] [Abstract][Full Text] [Related]
10. Fagales pollen sensitization in a birch-free area: a respiratory cohort survey using Fagales pollen extracts and birch recombinant allergens (rBet v 1, rBet v 2, rBet v 4).
Mari A; Wallner M; Ferreira F
Clin Exp Allergy; 2003 Oct; 33(10):1419-28. PubMed ID: 14519150
[TBL] [Abstract][Full Text] [Related]
11. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
Gafvelin G; Thunberg S; Kronqvist M; Grönlund H; Grönneberg R; Troye-Blomberg M; Akdis M; Fiebig H; Purohit A; Horak F; Reisinger J; Niederberger V; Akdis CA; Cromwell O; Pauli G; Valenta R; van Hage M
Int Arch Allergy Immunol; 2005 Sep; 138(1):59-66. PubMed ID: 16103688
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of Bip 1, a monoclonal antibody that modulates IgE binding to birch pollen allergen, Bet v 1.
Laffer S; Vangelista L; Steinberger P; Kraft D; Pastore A; Valenta R
J Immunol; 1996 Dec; 157(11):4953-62. PubMed ID: 8943401
[TBL] [Abstract][Full Text] [Related]
13. Crystallization and preliminary X-ray investigation at 2.0 A resolution of Bet v 1, a birch pollen protein causing IgE-mediated allergy.
Spangfort MD; Larsen JN; Gajhede M
Proteins; 1996 Nov; 26(3):358-60. PubMed ID: 8953655
[TBL] [Abstract][Full Text] [Related]
14. Allergy vaccine engineering: epitope modulation of recombinant Bet v 1 reduces IgE binding but retains protein folding pattern for induction of protective blocking-antibody responses.
Holm J; Gajhede M; Ferreras M; Henriksen A; Ipsen H; Larsen JN; Lund L; Jacobi H; Millner A; Würtzen PA; Spangfort MD
J Immunol; 2004 Oct; 173(8):5258-67. PubMed ID: 15470071
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in the polyclonal T cell response to birch pollen allergens.
Dormann D; Montermann E; Klimek L; Weber B; Ebner C; Valenta R; Kraft D; Reske-Kunz AB
Int Arch Allergy Immunol; 1997 Nov; 114(3):272-7. PubMed ID: 9363909
[TBL] [Abstract][Full Text] [Related]
16. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4.
Twardosz A; Hayek B; Seiberler S; Vangelista L; Elfman L; Grönlund H; Kraft D; Valenta R
Biochem Biophys Res Commun; 1997 Oct; 239(1):197-204. PubMed ID: 9345295
[TBL] [Abstract][Full Text] [Related]
18. Recombinant birch pollen allergens (rBet v 1 and rBet v 2) contain most of the IgE epitopes present in birch, alder, hornbeam, hazel, and oak pollen: a quantitative IgE inhibition study with sera from different populations.
Niederberger V; Pauli G; Grönlund H; Fröschl R; Rumpold H; Kraft D; Valenta R; Spitzauer S
J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):579-91. PubMed ID: 9802365
[TBL] [Abstract][Full Text] [Related]
19. Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001.
Smole U; Balazs N; Hoffmann-Sommergruber K; Radauer C; Hafner C; Wallner M; Ferreira F; Grössinger R; de Jong EC; Wagner S; Breiteneder H
Immunobiology; 2010 Nov; 215(11):903-9. PubMed ID: 20005001
[TBL] [Abstract][Full Text] [Related]
20. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
